Immune-Based Prediction of COVID-19 Severity and Chronicity Decoded Using Machine Learning
December 22, 2020
Evidence to why Long-Haulers are still ill
December 22, 2020
Leronlimab Used in Seven Patients with Severe COVID-19
March 27, 2020
CytoDyn Files FDA Suggested Modifications to IND 400
March 27, 2020
U.S. Food and Drug Administration (FDA) Grants Emergency IND for Two Coronavirus Patients Treated in New York with CytoDyn’s Leronlimab
March 19, 2020
CytoDyn Signs Letter of Intent for the Joint Development and Licensing of Leronlimab in China with Longen China Group
February 12, 2020
IncellDx and CytoDyn in discussions with potential partners about the use of leronlimab to treat 2019 Novel Coronavirus (2019-nCoV)
January 28, 2020